Last update 20 Dec 2024
Caffeine/Propranolol
Last update 20 Dec 2024
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms- |
Mechanism A1R antagonists(Adenosine A1 receptor antagonists), A2aR antagonists(Adenosine A2a receptor antagonists), β-adrenoceptors antagonists(Beta adrenergic receptors antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization- |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Structure
Molecular FormulaC8H10N4O2 |
InChIKeyRYYVLZVUVIJVGH-UHFFFAOYSA-N |
CAS Registry58-08-2 |
View All Structures (2)
Related
1
Clinical Trials associated with Caffeine/PropranololRandomized Double-Blind Study to Evaluate the Dose-Related Efficacy and Safety of Caffeine/Propranolol in the Treatment of Acute Migraine
100 Clinical Results associated with Caffeine/Propranolol
Login to view more data
100 Translational Medicine associated with Caffeine/Propranolol
Login to view more data
100 Patents (Medical) associated with Caffeine/Propranolol
Login to view more data
100 Deals associated with Caffeine/Propranolol
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Stress Disorders, Post-Traumatic | Phase 1 | US | 24 Jan 2022 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Phase 2 | 60 | placebo (Placebo) | gzqabhrvxr(yghixslatd) = vocxabzfxx qncxewmqsr (ggfzkshlyj, oszwubndxd - wspwfizcly) View more | - | 24 Feb 2017 | ||
(Low Dose) | gzqabhrvxr(yghixslatd) = svqiqdnxue qncxewmqsr (ggfzkshlyj, wsjdznvjvt - wiyxawlgmf) View more |
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free